title: Serious liver disease in a patient receiving methotrexate and leflunomide.
authors.affiliation: Brigham and Women's Hospital, Boston, MA, USA.
authors.forename: M E
authors.initials: ME
authors.lastname: Weinblatt
authors.forename: J A
authors.initials: JA
authors.lastname: Dixon
authors.forename: K R
authors.initials: KR
authors.lastname: Falchuk
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use* / Q000633:toxicity; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use* / Q000633:toxicity; D007555:Isoxazoles / Q000627:therapeutic use* / Q000633:toxicity; D000077339:Leflunomide; D008099:Liver / Q000201:enzymology; D008103:Liver Cirrhosis / Q000139:chemically induced*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use* / Q000633:toxicity; D008875:Middle Aged; D012720:Severity of Illness Index
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide; D008727:Methotrexate